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This study was conducted to explore the functional relationship between oxygen concentration 
during tissue reoxygenation after ischemia and the extent of postischemic lipid peroxidation, an 
indicator of reoxygenation injury. Excised rat liver or kidney tissue was rendered ischemic for 1 
h at 37°C, minced into 1 mm
3
 fragments, and then reoxygenated for 1 h in flasks of buffered salt 
solution containing various amounts of oxygen. Production of malondialdehyde-like material 
(MDA) was measured to indicate lipid peroxidation. MDA production was minimal at oxygen 
tensions less than 10 mmHg, increased sharply from 10 to 50 mmHg, and plateaued at 
approximately 100 mmHg. A similar functional relationship was produced by a simple 
mathematical model of free radical mediated lipid peroxidation in biological membranes, 
suggesting that MDA production is indeed caused by free radical oxidation of membrane 
phospholipids and that the oxygen effect is governed by simple competition between chain 
propagation and chain termination reactions within the membrane. These experimental and 
analytical results confirm that relatively low concentrations of oxygen arc sufficient to produce 
oxidative damage in post-ischemic tissues. 
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The concept of reperfusion or reoxygenation injury implies that an important component of 
tissue damage observed after a period of ischemia and reperfusion is caused by events during the 
reperfusion phase, which necessarily involve the return of molecular oxygen. By most accounts, 
the injury associated with reoxygenation is initiated by the formation of active oxygen species 
such as the superoxide radical (O2

) and hydrogen peroxide (H2O2). These can compound 
primary ischemic injury by a variety of possible mechanisms, including the generation of highly 
reactive hydroxyl radicals (HO) via the iron catalyzed Haber-Weiss reaction and subsequent 
initiation of lipid peroxidation in biological membranes, which then proceeds by radical chain 
mechanisms [1-5]. 
 
Many studies of reperfusion and/or reoxygenation injury, including our own [6, 7] and especially 
those utilizing isolated, perfused hearts [8-11], have been done using 95 to 100% oxygen for 
reoxygenation after ischemia or hypoxia. Ranges of oxygen concentration are generally not 
tested. If toxic free radicals were formed only at high oxygen tensions, for example PO2 >100 
mmHg, as might occur in vascular endothelial cells, then one simple strategy to minimize 
reoxygenation injury in clinical practice would be to resuscitate with room air rather than 
oxygen. 
 
To date, the oxygen requirements for free radical formation and/or lipid peroxidation in 
postischemic tissues have not been rigorously studied. Demopolous [12], for example, addressed 
this issue only in terms of idealized curves. The large rate constant for the addition of oxygen to 






) [13], would seem to indicate that 
only low PO2's are necessary for lipid peroxidation. However, there are many competing 
reactions and complexities of free radical chemistry in vivo that could allow for the formation of 
other products. 
 
If the toxic effects of oxygen after ischemia were to occur only at relatively high oxygen 
concentrations, while the beneficial effects of reoxygenation were achieved at lower 
concentrations, then a therapeutic window for postischemic oxygen therapy would exist that 
would permit restoration of aerobic metabolism with minimum reoxygenation injury. In support 
of this possibility are Negovskii's intriguing studies of the 1960s, in which dogs resuscitated 
from hemorrhagic shock with 100% oxygen developed microhemorrhages in the brain [14], 
while those similarly resuscitated with room air did not. On the other hand, if the toxic effects of 
oxygen in postischemic tissues appear at concentrations similar to those necessary to restore 
mitochondrial function, then the potential for reoxygenation injury is an inevitable 
accompaniment to oxygen therapy and must be suppressed by other strategies. 
 
To investigate oxygen effects after ischemia we used tissue slices incubated in short term organ 
culture, as originally described for the study of carbon tetrachloride toxicity by Tappel and 
coworkers [15, 16] and subsequently modified in our laboratory for the study of reoxygenation 
injury [17]. Tissue slices offer a useful and convenient compromise between biochemical and 
physiological model systems. The microscopic organization of tissues is preserved, while the 
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chemical composition, including, in particular, the PO2 of the incubation media, can be easily 
and precisely controlled to mimic the extracellular milieu in bulk tissues. When the thickness of 
the tissue slices is approximately 1 mm, the oxygen gradients that develop with distance from the 
surface are similar to those that develop in vivo with distance from perfused capillaries [18]. 
Moreover, tissues may be conveniently exposed to a cycle of ischemia and reoxygenation by pre-
incubating freshly excised tissue in humidified argon gas, prior to mincing and subsequent 
incubation in oxygen containing buffer. 
 
The production of tbiobarbituric acid reactive substances or malondialdehyde equivalents, for 
simplicity abbreviated here as MDA equivalents, provides a sensitive indicator of free radical 
dependent reoxygenation injury. Our previous studies with tissue slices [17] had shown that 
MDA equivalent production by postischemic rat liver and kidney is abolished by treatment with 
the iron chelator deferoxamine, the liposoluble, chain breaking antioxidant, BHT, and by 
methylene blue, which probably acts to inhibit production of superoxide by xanthine oxidase 
[19]. This simple system would thus appear to exhibit the classical features of reoxygenation 
injury as proposed by Saugstad [20] and McCord [1]--dependence upon enzymatically generated 
superoxide, upon the iron catalyzed Haber Weiss reaction, and upon free radical chain 
oxidations. Accordingly, we conducted the following study to determine the functional 
relationship between oxygen concentration during the post-ischemic period and one well-known 







TRIS buffer and 2-thiobarbituric acid were obtained from Sigma Chemical Company (St. Louis, 
MO 63178), trichloroacetic acid from Fisher Scientific Company (Fair Lawn, NJ 07410), and 
methylene blue, from Aldrich Chemical Company (Milwaukee, WI 53233). Deferoxamine, Lot 
#30315, was kindly provided by CIBAGEIGY Pharmaceuticals Division (Suffern, NY 10901). 
The TRIS-Ringer buffer solution consisted of 4.0 mM KC1, 100 mM NaCl, 2.0 mM CaCl2, 40 
mM TR1S buffer, and 200 mg/dL glucose, pH 7.4. TRIS buffer was chosen rather than 
phosphate because its solubility in the presence of calcium permitted a greater buffering capacity 




Tissues were taken from 30 male Wistar rats which were anesthetized with sodium pentobarbitol 
(60 mg/ kg, i.p.). Rat liver and kidney were selected for study because they produce abundant 
MDA equivalents in this model of ischemia/reoxygenation [17], and so provide a good basis for 
the study of oxygen effects. The liver and kidneys were excised, and tissue samples of 
approximately 0.3-0.4 grams were then placed into stoppered 50 ml Erlenmeyer flasks 
containing argon saturated (anoxic) TRIS-Ringer solution. Liver and kidney tissues were 
separately divided among 9 flasks, making a total of 18 flasks, which included ischemic but not 
reoxygenated controls and eight flasks for each tissue that were resupplied with various amounts 






For the ischemic phase, the 50 ml Erlenmeyer flasks, with tissue samples and 3.9 ml of 
argonated TRIS-Ringer buffer were flushed with argon gas, re-stoppered, and kept in a warmed, 
37°C, non-shaking water bath for 50 min to create ischemia. The tissues were not minced or 
shaken at this time to minimize the diffusion of metabolites from the tissue into the media, which 
does not occur in vivo during ischemia. 
 
Tissue mincing and drug treatment 
 
After the 50 min of ischemia, the tissues were minced with iris scissors to a size of 
approximately 1 mm on a side. Mincing was done to provide greater surface area for subsequent 
oxygen diffusion during the reoxygenation phase and also to promote greater drug distribution 
into the tissue slices that were treated with drugs. In some experiments, deferoxamine or 
methylene blue was added prior to reoxygenation. These drugs were dissolved in 0.1 ml of TRIS 
Ringer buffer and added to the flasks to achieve a final concentration of deferoxamine 100 mg/L 
(150 M), or methylene blue 10 mg/L (27 M). Non-drug treated flasks received 0.1 ml buffer. 
After the addition of the treatment to each flask, the head spaces of the flasks were quickly 
flushed with argon gas. Because the density of argon is greater than that of oxygen, there was 
little contamination of the buffer and tissues with oxygen during the mincing and treatment 
phase. The flasks were then recapped, swirled gently, and returned to the 37°C water bath for 10 




After the 60 min of ischemic anoxia, a volume (V1) of argon was removed from each flask and a 
volume (V2) of oxygen gas was added so as to achieve a specified oxygen concentration ranging 
from 0 to 100%, and corresponding to calculated partial pressures of 0, 5, 10, 20, 40, 100, 250, 
500, and 700 mmHg. Argon was removed and oxygen was added via a stopcock and 18 gauge 
needle, inserted through the rubber stopper of each flask, to which a syringe could be attached. 
The correct volumes, V1 and V2 , of gases to withdraw and add back were calculated using the 
ideal gas law (PV = nRT).  
 
After introduction of oxygen, all flasks were returned to a 37°C shaking water bath for 60 min of 
reoxygenation. The PO2's within the flasks prepared by this procedure were checked by injecting 
the buffers into a Corning Model 165 pH Blood Gas Analyzer. Four samples were tested at each 
specified PO2. The relation between measured PO2 and calculated (target) PO2 is presented in 
Table 1. From the linear regression function for these data, the prevailing PO2 was calculated for 
all similarly prepared flasks. These measured values were used as the independent variable, PO2, 
in preparing plots. Metabolic oxygen demand of the tissues (about 0.2 ml O2/h) was negligible 
with respect to the amount of oxygen available in the flask, for all oxygen concentrations greater 
than 1%, hence we assumed that oxygen concentration in the flasks did not change as a result of 










Thiobarbituric acid assay for malondialdehyde 
 
Malondialdehyde was measured by the spectrophotometric method of Buege and Aust [21]. 
Flask contents, including tissue and buffer were homogenized in a Teflon/glass homogenizer. 
The total homogenate was combined with 4.0 ml of TCA-TBA reagent [21] in a test tube and 
mixed thoroughly. Each tube was covered with a glass marble and heated for 15 min in a 
temperature controlled heating block (Dri-bath) at 90-95°C. After cooling, the flocculent 
precipitate was removed by centrifugation at 1500 g for 5 min. The absorbance of the 
supernatant was determined spectrophotometrically at 500, 530, and 560 nm against a blank 
containing 4 ml of TCA-TBA reagent, 3.9 ml buffer and 0.1 ml of the corresponding drug or 
buffer. Standard curves were prepared using authentic malonaldehyde (bis-dimethylacetal)  
[1,1,3,3-tetramethoxypropane], available from Aldrich Chemical Company, Inc. (Milwaukee, WI 
53233, Cat # 10,838-3). 
 
A simple double derivative technique [17, 22] was used to calculate the concentration of MDA 











where subscripts represent wavelengths in nanometers,  A  is absorbance, the constants b500 = 
A500/A530 for authentic MDA standard, and b560 = A560/A530 for authentic MDA standard,   is the 






), and  d  is the light path 
length through the cuvet. This relationship, derived previously [17], provides a measure of 
concentration based upon the 530 nm peak of genuine MDA, which is insensitive to background 






For each tissue type an analysis of variance (ANOVA) was run to test the null hypotheses that 
(1) MDA equivalent production was the same at all of the PO2's and (2) MDA equivalent 
production was the same for all drug treatments. The ANOVA was preceded by a Bartlett's chi-
square test for homogeneity of variance [23]. If the variances of compared data sets were not 
similar, a logarithmic transformation of the data was performed [24] and the ANOVA repeated 
on the transformed data. Specific comparisons were made using Duncan's multiple range test. A 





Figures 1 and 2 illustrate the effects of various PO2’s on the postischemic production of MDA 
equivalents in rat liver and kidney respectively. The data are plotted as mean  standard error for 
n = 10 organs in each group. In both liver and kidney of the rat, production of MDA equivalents 
increases sharply as PO2 increases from 0 to 50 mmHg, and then begins to plateau. MDA 
equivalent production was quenched in the methylene blue and deferoxamine treated tissues, 
compared to the untreated organs. In the untreated liver and kidney, all differences between 
reoxygenated and non-reoxygenated organs were statistically significant. Analysis of drug 
treatments showed that production of MDA equivalents in methylene blue and deferoxamine 







Fig. 1. Production of malondialdehyde equivalents (MDA) in rat liver slices during 1 h 
reoxygenation after 1 h warm ischemia at 37°C. Error bars represent  1 SEM. PO2, 
values plotted are measured levels determined during preliminary experiments (Table 
1) for each oxygen/argon mixture. Untreated liver generates MDA equivalents during 
reoxygenation in an oxygen dependent manner. Both methylene blue and 








Fig. 2. Production of malondialdehyde equivalents (MDA) in rat kidney slices during 
1h reoxygenation after 1 h warm ischemia at 37°C. Error bars represent  1 SEM. PO2 
values plotted arc measured levels determined during preliminary experiments (Table 
1) for each oxygen/argon mixture. Untreated kidney generates MDA equivalents 
during reoxygenation in an oxygen dependent manner. Methylene blue suppresses and 







The present study illustrates the strong dependence of the formation of postischemic oxidation 
products, measured as MDA equivalents, upon the prevailing oxygen concentration. Preliminary 
computer modeling of this phenomenon by an approach previously described [25] suggested that 
in essence the oxygen dependence of membrane lipid peroxidation can be explained by a much 
simpler series of competing reactions in phospholipid membranes themselves. These reactions 














Swern [32] has given a general expression for the kinetics of such oxidations in which the 










From this expression the shape of the function relating the rate of lipid oxidation to oxygen 
concentration, which is of immediate interest, can be expressed as a percentage of the maximal 




in which the concentration of unsaturated lipids in membrane material per se can be estimated to 
be about 1 M from typical densities and molecular weights of membrane phospholipids and 
allowing about 30% of the interior membrane volume for proteins and non-oxidizable 
components. Then, taking the values for k2 through k6 just presented to obtain k" and plotting the 
results in relation to experimental data from the present study, one finds the relationships 
presented in Figure 3. On the whole, the shapes of the oxygen dependence curves that we 
obtained for liver and kidney experimentally are explained by the six-reaction model (dashed 







Fig. 3. Relative MDA equivalent (MDA) production as a function of oxygen tension 
obtained experimentally (solid curves) and theoretically (dashed curve), expressed as a 
percent of maximal response, assuming approximately 95% maximal response at 700 
mmHg. A conversion of 1 M oxygen = 0.7 mmHg partial pressure of oxygen was 
assumed in plotting the dashed curve, which was obtained from the expression  
r = 100 [O2]/(k" [LH] + [O2]), using a membrane compartment lipid concentration, 
[LH], of 1 M and a dimensionless hybrid constant, k" of 50 × 10
6
, as defined in the 
text. The oxygen effect is reasonably well predicted by the theoretical expression, which 






Our interpretation of the observed oxygen effect in the tissue slice model is that it reflects the 
competition between chain propagation and chain termination reactions for lipid peroxidation 
within biological membranes. A related implication of this interpretation is that membrane lipids 
are indeed the major source of MDA-equivalents in this system, although it is well known that 
MDA-like materials can also be produced from the oxidation of nucleic acids, amino acids and 
certain complex carbohydrates [33-36]. The ability of the highly lipid soluble antioxidant, 
butylated hydroxytoluene (BHT), to abolish production of MDA equivalents under conditions of 
ischemia and reoxygenation identical to those of the present study [17] also suggests to us that 
most of the measured MDA-equivalents are coming from the lipid compartment. 
 
The pathophysiologic implication of the observed oxygen effect is that the critical extracellular 
PO2 necessary for reperfusion injury is relatively low. It we equate the oxygen concentration in 
our experimental incubation flasks with that in arterial blood, recognizing that diffusion into 
tissue must occur in each case, then about half the maximal effect is observed with a prevailing 
PO2 of only 40 mmHg. Since the normal arterial PO2 of a subject breathing room air is 
approximately 100 mmHg, this finding suggests the inevitability of some degree of membrane 
oxidation during reperfusion. We thus found no evidence for the existence of a therapeutic 
window of oxygen concentrations sufficient to restore aerobic metabolism after ischemia with 
minimal risk of reoxygenation injury.  
 
Indeed, our results are quite consistent with the proposition of Downey and coworkers [37] that 
reperfusion injury can occur without reperfusion in small myocardial infarcts supplied by 
tenuous collateral circulation. That is, even though a coronary artery occlusion is never re-
opened, oxygen radical injury may occur in the subepicardial regions and border zones of the 
resulting infarct, owing to residual oxygen delivery provided by collateral vessels. This 
proposition is supported by the clinical observation that plasma levels of MDA-like materials in 
patients with acute myocardial infarction, in the absence of thrombolytic therapy, are twice those 
of healthy subjects without infarction [38].  
 
Inhibition of MDA equivalent production in our tissue slice model, regardless of oxygen tension, 
by both deferoxamine and methylene blue is also interesting. This finding is consistent with a 
Haber-Weiss-Fenton mechanism for initiation of lipid peroxidation [39] as well as with the 
mechanism involving a ferrous-dioxygenferric chelate complex, proposed by Aust and 





We studied methylene blue because it is well absorbed into tissue slices [17] and because its 
mechanism of xanthine oxidase inhibition probably suppresses superoxide production by the 
enzyme without blocking oxidation of hypoxanthine or xanthine or formation of urate [19, 43, 
44]. The proposed chemistry is as follows. Methylene blue competes with molecular oxygen to 
accept electrons from xanthine oxidase, forming leukomethylene blue. The leukomethylene blue 
promptly autoxidizes back to the blue form with production of hydrogen peroxide directly, 
bypassing the formation of superoxide, as has been shown in vitro in the presence of 
cytochrome-c and oxygen [45]. Thus the net reaction in the presence of both xanthine oxidase 
and methylene blue is  
 
xanthine + O2 + 2 H
+
  uric acid + H2O2. 
 
Assuming this mechanism, one can interpret our results with methylene blue as further 
circumstantial evidence that both superoxide and xanthine oxidase are involved in postischemic 
lipid peroxidation. Further, the importance of superoxide as a reductant of chelated ferric iron 
[46] is indirectly confirmed, since the presumed excess H2O2, alone is inadequate to induce 





This report characterizes experimentally the dependence of postischemic lipid peroxidation, 
indicated by formation of malondialdehyde-like materials in liver and kidney tissue, upon 
oxygen concentration, and suggests that the observed effect is explained fundamentally by the 
balance of chain propagation and chain termination reactions for free radical mediated lipid 
peroxidation within biological membranes. The process is clearly dependent upon the availability 
of oxygen and iron, and may also require superoxide production by xanthine oxidase or a related 
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